BioSpace News Archive

Study to evaluate the Company’s Thin Film Freezing technology to formulate dry powder universal influenza vaccines for pulmonary delivery

Vicromax shown to decrease viral production of Covid -19 coronavirus by over 98% Article highlights recent work done in laboratory studies of Covid -19 with Vicromax(tm) at the Galveston Lational Laboratory at The University of Texas Medical Branch BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform, today announce

PDS Biotechnology Corporation today announced that it has appointed Ilian Iliev, Ph.D. to its Board of Directors. “We are very pleased to welcome Dr. Iliev to the Board of Directors. He brings a wealth of experience to PDS Biotech as a recognized entrepreneur and venture capital

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that a regulatory submission has been made to the Ministry of Food and Drug Safety in South Korea for an investigator-led Phase 2 COVID-19 study of its re-purposed drug NP-120 (Ifenprodil).

Research to evaluate whether combination treatments of antimalarial drugs and antibiotics decrease respiratory symptoms for COVID-19 patients

Quest International, Inc., the global leading service provider specializing in depot repairs, field services, and supply chain logistics for medical device manufacturers, announced the expansion of their ISO 13485 certified service infrastructure in response to the surge in demand for the assembly and servicing of ventilators and related critical medical devices due to COVID-19.

Xyntek Inc, is proud to announce that it is entering into a new era, announcing a new company structure under the name CXV Global Ltd. This agreement will now bring together three long-time partner companies ( Crest Solutions , Xyntek and VistaLink) under the umbrella name of CXV Global to create a single source solution g

LabLynx, Inc., long-time leader in enterprise-level cloud-hosted LIMS/LIS, today announced it has developed the world’s first LIMS (Laboratory Information Management System) dedicated specifically to COVID-19 diagnostic testing.

Tenax Therapeutics, Inc. today announced that the last patient has completed their final visit in the Company’s Phase 2 clinical trial of levosimendan in patient

ReAlta Life Sciences, Inc., a biotech company dedicated to harnessing the power of the immune system through its PIC1 technology platform to address life-threatening medical needs, today announced that it has appointed Jonathan Zalevsky, Ph.D., an immunology expert, and Christine Neikirk, a governance and marketing expert, to its board of directors.